Position in UTHR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$477,941
+$85,218 QoQ
Shares Held
806
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Claret Asset Management Corp holds $23,258,930 across 6 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
707,267 | $21,557,498 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
806 | $477,941 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
16,017 | $383,286 | |
| 4 | VTRS |
Viatris Inc
|
26,710 | $360,852 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,923 | $253,336 | |
| 6 | ZTS |
Zoetis Inc.
|
1,912 | $226,017 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $477,941 | 806 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $392,723 | 806 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $338,721 | 808 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $235,339 | 819 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $212,089 | 688 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $242,753 | 688 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $244,753 | 683 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $216,295 | 679 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||